Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:5.99.1.3 (
topoisomerase
)
9,911
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Several
DNA topoisomerase II
(Topo II;
EC 5.99.1.3
) partial cDNA clones obtained from a human Raji-
HN2
cDNA library were sequenced and two classes of nucleotide sequences were found. One member of the first class, SP1, was identical to an internal fragment of human HeLa cell Topo II cDNA described earlier. A member of the second class, SP11, shared extensive nucleotide (75%) and predicted peptide (92%) sequence similarities with the first two-thirds of HeLa Topo II. Each class of cDNAs hybridized to unique, nonoverlapping restriction enzyme fragments of genomic DNA from several human cell lines. Synthetic 24-mer oligonucleotide probes specific for each cDNA class hybridized to 6.5-kilobase mRNAs; furthermore, hybridization of probe specific for one class was not blocked by probe specific for the other. Antibodies raised against a synthetic SP1-encoded dodecapeptide specifically recognized the 170-kDa form of Topo II, while antibodies raised against the corresponding SP11-encoded dodecapeptide, or a second unique SP11-encoded tridecapeptide, selectively recognized the 180-kDa form of Topo II. These data provide genetic and immunochemical evidence for two Topo II isozymes.
...
PMID:Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isozymes. 255 12
A human Burkitt's lymphoma cell line (Raji-
HN2
) made resistant to nitrogen mustard, a bifunctional alkylating agent, was used to study the mechanism of resistance to nitrogen mustard. A comparative study of Raji-
HN2
and the parental sensitive Raji cell lines revealed the following: (1) The DNA of Raji-
HN2
cells was crosslinked by nitrogen mustard to a lower extent than Raji DNA; (2) once interstrand crosslinks were formed, they were repaired at the same rate in both cell lines; (3) DNA crosslink formation in Raji-
HN2
, but not in Raji cells, was enhanced by novobiocin, a
topoisomerase
II inhibitor; (4) Raji-
HN2
cells had elevated
topoisomerase
II activity and were hypersensitive to
topoisomerase
inhibitors (amsacrine, novobiocin, teniposide); (5) similar amounts of topoisomerase I were found in both cell lines; and (6) the chromatin of Raji-
HN2
but not of Raji cells, was hypersensitive to DNase I digestion. The relationship between DNA repair,
topoisomerase
II activity, chromatin structure and drug resistance is discussed.
...
PMID:Elevated topoisomerase II activity and altered chromatin in nitrogen mustard-resistant human cells. 281 39
A human Burkitt lymphoma cell line, Raji-
HN2
, made 10-fold more resistant to nitrogen mustard (
HN2
) than the parental Raji cell line, exhibited the following characteristics when compared to the parental Raji cells: (i) decreased
HN2
-induced DNA interstrand crosslinking; (ii) increased (3-fold)
DNA topoisomerase II
[DNA topoisomerase (ATP-hydrolyzing),
EC 5.99.1.3
] activity; (iii) increased (4- to 11-fold) sensitivity to
topoisomerase
II inhibitors; (iv) increased (2-fold) glutathione content; and (v) increased (2-fold) cell doubling time. The resistant phenotype was unstable and was maintained by weekly treatment of the cells with
HN2
. Growing the resistant cells in the absence of
HN2
resulted in a time-dependent decrease in both resistance to
HN2
and
topoisomerase
II activity and an increase in DNA interstrand crosslinking induced by
HN2
. We hypothesize that
HN2
resistance is due to enhanced monoadduct repair with resultant decreased DNA crosslinking and that this process is mediated by
topoisomerase
II.
...
PMID:Elevated DNA topoisomerase II activity in nitrogen mustard-resistant human cells. 282 70